Canadian Journal on Aging / La Revue canadienne du vieillissement,
Год журнала:
2024,
Номер
unknown, С. 1 - 9
Опубликована: Март 8, 2024
Abstract
Behavioural
treatments
are
recommended
first-line
for
insomnia,
but
long-term
benzodiazepine
receptor
agonist
(BZRA)
use
remains
common
and
engaging
patients
in
a
deprescribing
consultation
is
challenging.
Few
interventions
directly
target
patients.
Prescribers’
support
of
patient-targeted
may
facilitate
their
uptake.
Recently
assessed
the
Your
Answers
When
Needing
Sleep
New
Brunswick
(YAWNS
NB)
study,
Sleepwell
(mysleepwell.ca)
was
developed
as
direct-to-patient
behaviour
change
intervention
promoting
BZRA
non-pharmacological
insomnia
management.
prescribers
YAWNS
NB
participants
were
invited
to
complete
an
online
survey
assessing
acceptability
intervention.
The
using
seven
construct
components
theoretical
framework
(TFA)
framework.
Respondents
(40/250,
17.2%)
indicated
high
acceptability,
with
positive
responses
per
TFA
averaging
32.3/40
(80.7%).
Perceived
ethical,
credible,
useful
tool,
also
promoted
prescriber–patient
engagements
(11/19,
58%).
Prescribers
accepting
supported
its
application
Methods and Protocols,
Год журнала:
2024,
Номер
7(2), С. 26 - 26
Опубликована: Март 22, 2024
Introduction:
Virtually
all
adults
in
aged
care
facilities
are
frail,
a
condition
which
contributes
to
falls,
cognitive
decline,
hospitalisation,
and
mortality.
Polypharmacy,
malnutrition,
sedentariness,
sarcopenia
risk
factors
amenable
intervention.
The
Asia–Pacific
Frailty
Management
Guidelines
recommend
anabolic
exercise
the
optimisation
of
medications
nutrition.
However,
no
study
has
evaluated
this
best
practice
intervention
triad
care.
Methods:
Reduction
via
Implementation
Exercise,
Nutrition,
Deprescribing
(FRIEND)
Trial
(ANZCTR
No.ACTRN12622000926730p)
is
staged
6-month
translational
trial
evaluating
resident
outcomes,
staff/caregiver
knowledge,
institutional
implementation
Townsville
facility.
Residents
received
high-intensity
resistance
balance
training
medication
nutrition
co-implemented
by
investigators
(exercise
physiologist,
geriatrician,
pharmacist,
nutritionist)
facility
staff.
Staff
caregivers
completed
comprehensive
education
modules
training.
We
report
protocol
recruitment
results.
Results:
29
residents
(21
female,
age:
88.6
±
6.3
years)
were
recruited.
At
baseline,
frail
(frailty
scale
nursing
home
(FRAIL-NH);
2.4/14),
cognitively
impaired
(Montreal
Cognitive
Assessment;
13.8
6.8/30),
functionally
(Short
Physical
Performance
Battery;
4.9
3.1/12,
6
min
walk
distance;
222.2
104.4
m),
prescribed
numerous
(15.5
5.9).
Two
died
one
withdrew
before
intervention’s
commencement.
Thirty
family
members
19
staff
(carers,
allied
health
assistants,
nurse
managers,
registered
nurses,
lifestyle–leisure
officers,
kitchen/hospitality
staff,
senior
leadership)
recruited
receive
frailty
modules.
Conclusions:
FRIEND
currently
being
implemented
with
results
expected
mid-2024.
This
first
evaluate
guidelines
including
medication/nutritional
residential
Canadian Journal on Aging / La Revue canadienne du vieillissement,
Год журнала:
2024,
Номер
unknown, С. 1 - 9
Опубликована: Март 8, 2024
Abstract
Behavioural
treatments
are
recommended
first-line
for
insomnia,
but
long-term
benzodiazepine
receptor
agonist
(BZRA)
use
remains
common
and
engaging
patients
in
a
deprescribing
consultation
is
challenging.
Few
interventions
directly
target
patients.
Prescribers’
support
of
patient-targeted
may
facilitate
their
uptake.
Recently
assessed
the
Your
Answers
When
Needing
Sleep
New
Brunswick
(YAWNS
NB)
study,
Sleepwell
(mysleepwell.ca)
was
developed
as
direct-to-patient
behaviour
change
intervention
promoting
BZRA
non-pharmacological
insomnia
management.
prescribers
YAWNS
NB
participants
were
invited
to
complete
an
online
survey
assessing
acceptability
intervention.
The
using
seven
construct
components
theoretical
framework
(TFA)
framework.
Respondents
(40/250,
17.2%)
indicated
high
acceptability,
with
positive
responses
per
TFA
averaging
32.3/40
(80.7%).
Perceived
ethical,
credible,
useful
tool,
also
promoted
prescriber–patient
engagements
(11/19,
58%).
Prescribers
accepting
supported
its
application
